Literature DB >> 21199906

Proton pump inhibitor side effects and drug interactions: much ado about nothing?

Ryan D Madanick1.   

Abstract

Proton pump inhibitors (PPIs) are widely prescribed for acid-peptic disease. In general, the safety of this class of drugs has been excellent. However, in the past several years, epidemiologic studies have indicated possible risks that are biologically plausible.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21199906     DOI： 10.3949/ccjm.77a.10087

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  17 in total

Review 1.  The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.

Authors:  J Keller; T Schinke
Journal:  Osteoporos Int       Date:  2013-03-28       Impact factor: 4.507

2.  Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.

Authors:  Yohannes T Ghebremariam; Paea LePendu; Jerry C Lee; Daniel A Erlanson; Anna Slaviero; Nigam H Shah; James Leiper; John P Cooke
Journal:  Circulation       Date:  2013-07-03       Impact factor: 29.690

3.  Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients.

Authors:  In Hwan Lim; Seung Jae Lee; Byoung-Soo Shin; Hyun Goo Kang
Journal:  Biomedicines       Date:  2022-06-09

4.  Secretagogue-dependent and -independent transport of zinc hydration forms in rat parietal cells.

Authors:  Florentina Sophie Ferstl; Alice Miriam Kitay; Rebecca Marion Trattnig; Abrar Alsaihati; John Peter Geibel
Journal:  Pflugers Arch       Date:  2016-10-19       Impact factor: 3.657

5.  Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study.

Authors:  Srecko Marusic; Vesna Bacic-Vrca; Paulo Roque Obreli Neto; Miljenko Franic; Viktorija Erdeljic; Nives Gojo-Tomic
Journal:  Eur J Clin Pharmacol       Date:  2013-06-06       Impact factor: 2.953

Review 6.  How May Proton Pump Inhibitors Impair Cardiovascular Health?

Authors:  Roman A Sukhovershin; John P Cooke
Journal:  Am J Cardiovasc Drugs       Date:  2016-06       Impact factor: 3.571

7.  Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.

Authors:  Nigam H Shah; Paea LePendu; Anna Bauer-Mehren; Yohannes T Ghebremariam; Srinivasan V Iyer; Jake Marcus; Kevin T Nead; John P Cooke; Nicholas J Leeper
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 8.  Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events.

Authors:  Katelyn W Sylvester; Judy Wm Cheng; Mandeep R Mehra
Journal:  Vasc Health Risk Manag       Date:  2013-05-16

9.  In vitro antioxidant and H(+), K(+)-ATPase inhibition activities of Acalypha wilkesiana foliage extract.

Authors:  Rajesh Kashi Prakash Gupta; Manjunatha Hanumanthappa
Journal:  J Pharm Bioallied Sci       Date:  2013-07

Review 10.  Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?

Authors:  Cheryl Durand; Kristine C Willett; Alicia R Desilets
Journal:  Clin Med Insights Gastroenterol       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.